Close Menu

The Wall Street Journal reports that Congress members are pushing to transform the US FDA "by giving it broad powers to levy fines, order drug recalls and restrict drug-industry advertising," the article says. "The lawmakers say an FDA restructuring should build a much taller wall between the agency and the industry it regulates." The changes, if they happen, aren't expected to take place until next year.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.